Cargando…

Overcoming cohort heterogeneity for the prediction of subclinical cardiovascular disease risk

Cardiovascular disease remains a leading cause of mortality with an estimated half a billion people affected in 2019. However, detecting signals between specific pathophysiology and coronary plaque phenotypes using complex multi-omic discovery datasets remains challenging due to the diversity of ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Adam S., Wu, Songhua, Vernon, Stephen T., Tang, Owen, Figtree, Gemma A., Liu, Tongliang, Yang, Jean Y.H., Patrick, Ellis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182278/ https://www.ncbi.nlm.nih.gov/pubmed/37192969 http://dx.doi.org/10.1016/j.isci.2023.106633

Ejemplares similares

Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort
por: Zhu, Dantong, et al.
Publicado: (2023)

Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study
por: Vernon, Stephen T., et al.
Publicado: (2021)

A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types
por: Patrick, Ellis, et al.
Publicado: (2016)

Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART‐CT Study
por: Kott, Katharine A., et al.
Publicado: (2021)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
por: Lam, Stephen S.Y., et al.
Publicado: (2020)

Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
por: Kott, Katharine A, et al.
Publicado: (2019)

Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
por: Figtree, Gemma A., et al.
Publicado: (2022)

Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease
por: Sue, Laura Y., et al.
Publicado: (2020)

Subclinical Hypothyroidism and Cardiovascular Disease
por: Suh, Sunghwan, et al.
Publicado: (2015)

Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk‐Enhancing Factor in the Pooled Cohort Equation: A Cost‐Effectiveness Analysis Study
por: Mujwara, Deo, et al.
Publicado: (2022)

Combining structured and unstructured data in EMRs to create clinically-defined EMR-derived cohorts
por: Tam, Charmaine S., et al.
Publicado: (2021)

The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review
por: Saleh, Soloman, et al.
Publicado: (2022)

Progression of coronary atherosclerosis in patients without standard modifiable risk factors
por: Mazhar, Jawad, et al.
Publicado: (2020)

Biological markers of oxidative stress: Applications to cardiovascular research and practice()
por: Ho, Edwin, et al.
Publicado: (2013)

ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
por: Vernon, Stephen T., et al.
Publicado: (2019)

Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease
por: Kott, Katharine A, et al.
Publicado: (2023)

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
por: Fang, Michael, et al.
Publicado: (2023)

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events
por: Acquah, Isaac, et al.
Publicado: (2023)

Overcoming Shellfish Allergy: How Far Have We Come? †
por: Wai, Christine Y.Y., et al.
Publicado: (2020)

The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field
por: Coorey, Genevieve, et al.
Publicado: (2022)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease
por: Kott, Katharine A., et al.
Publicado: (2023)

Preterm birth and future risk of maternal cardiovascular disease – is the association independent of smoking during pregnancy?
por: Ngo, Anh D., et al.
Publicado: (2015)

The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies
por: Sohn, Seo Young, et al.
Publicado: (2020)

Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz. in bovine subclinical mastitis
por: Xu, Wei, et al.
Publicado: (2015)

Association of Dietary Patterns Derived Using Reduced‐Rank Regression With Subclinical Cardiovascular Damage According to Generation and Sex in the STANISLAS Cohort
por: Wagner, Sandra, et al.
Publicado: (2020)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
por: van der Velde, Nikki, et al.
Publicado: (2021)

Prevalence of Subclinical Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease: Analysis of the Paracelsus 10,000 Cohort Study
por: Koutny, Florian, et al.
Publicado: (2023)

Prevalence of subclinical retinal ischemia in patients with cardiovascular disease – a hypothesis driven study
por: Long, Christopher P., et al.
Publicado: (2021)

Central Adiposity and Subclinical Cardiovascular Disease in Police Officers
por: Baughman, Penelope, et al.
Publicado: (2013)

Cardiovascular Risk Factors in Children and Adolescents with Subclinical Hypothyroidism
por: Yadav, Yogesh, et al.
Publicado: (2017)

Subclinical Hypothyroidism and Its Association with Increased Cardiovascular Mortality
por: Altamirano Ufion, Alvaro, et al.
Publicado: (2017)

Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
por: Szychlińska, Magdalena, et al.
Publicado: (2020)

Relationship Between Subclinical Hypothyroidism and the Risk of Cardiovascular Complications
por: Kaushik, Aashi, et al.
Publicado: (2023)

Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas
por: CAN, Bülent, et al.
Publicado: (2022)

Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
por: Mazhar, Jawad, et al.
Publicado: (2022)

Detectable Subclinical Myocardial Necrosis Is Associated With Cardiovascular Risk in Stable Patients With Diabetes
por: Tang, W.H. Wilson, et al.
Publicado: (2013)

Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2020)

A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
por: Kim, Taiyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jlivh7ebcuvuak1thturku3nss